Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kirk J Nelson"'
Autor:
Leslie W Tari, Xiaoming Li, Michael Trzoss, Daniel C Bensen, Zhiyong Chen, Thanh Lam, Junhu Zhang, Suk Joong Lee, Grayson Hough, Doug Phillipson, Suzanne Akers-Rodriguez, Mark L Cunningham, Bryan P Kwan, Kirk J Nelson, Amanda Castellano, Jeff B Locke, Vickie Brown-Driver, Timothy M Murphy, Voon S Ong, Chris M Pillar, Dean L Shinabarger, Jay Nix, Felice C Lightstone, Sergio E Wong, Toan B Nguyen, Karen J Shaw, John Finn
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84409 (2013)
Increasing resistance to every major class of antibiotics and a dearth of novel classes of antibacterial agents in development pipelines has created a dwindling reservoir of treatment options for serious bacterial infections. The bacterial type IIA t
Externí odkaz:
https://doaj.org/article/61b9ed4eb647499192d901bd0163432e
Autor:
Bryan P. Kwan, Kirk J. Nelson, Grayson Hough, John T. Finn, Karen Joy Shaw, Mark Hilgers, Mark L. Cunningham, Thanh Lam, Michael Trzoss, Vickie Brown-Driver, Voon Ong
Publikováno v:
Journal of Medicinal Chemistry. 57:651-668
A new series of dihydrofolate reductase (DHFR) inhibitors, the 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines, were designed and optimized for antibacterial potency and enzyme selectivity. The most potent inhibitors in this series contained a five-mem
Publikováno v:
SLAS Discovery. 18:1018-1026
The macromolecular synthesis assay was optimized in both S. aureus and E. coli imp and used to define patterns of inhibition of DNA, RNA, protein, and cell wall biosynthesis of several drug classes. The concentration of drug required to elicit pathwa
Autor:
Mark L. Cunningham, Doug Phillipson, Bryan P. Kwan, John T. Finn, Kirk J. Nelson, Sergio E. Wong, Michael Trzoss, Jeff B. Locke, Jay C. Nix, Vickie Brown-Driver, Felice C. Lightstone, Zhiyong Chen, Toan B. Nguyen, Karen J. Shaw, Suzanne Akers-Rodriguez, Xiaoming Li, Suk Joong Lee, Amanda Castellano, Dean L. Shinabarger, Timothy M. Murphy, Junhu Zhang, Leslie W. Tari, Chris M. Pillar, Voon Ong, Grayson Hough, Thanh Lam, Daniel C. Bensen
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84409 (2013)
PLoS ONE
PLoS ONE
Increasing resistance to every major class of antibiotics and a dearth of novel classes of antibacterial agents in development pipelines has created a dwindling reservoir of treatment options for serious bacterial infections. The bacterial type IIA t
Autor:
Vickie Brown-Driver, Christopher J. Creighton, John T. Finn, Toan B. Nguyen, Mark L. Cunningham, Zhiyong Chen, Amanda Castellano, Mark Stidham, Sergio E. Wong, Xiaoming Li, Karen J. Shaw, Thanh Lam, Junhu Zhang, Bryan P. Kwan, Kirk J. Nelson, Felice C. Lightstone, Leslie W. Tari, Daniel C. Bensen, Micheal Trzoss
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(5)
The structurally related bacterial topoisomerases DNA gyrase (GyrB) and topoisomerase IV (ParE) have long been recognized as prime candidates for the development of broad spectrum antibacterial agents. However, GyrB/ParE targeting antibacterials with
Autor:
Michael J. Hunter, Kirk J. Nelson, Ronald V. Swanson, Duncan E. McRee, Jay C. Nix, Daniel C. Bensen, Leslie W. Tari, Isaac Hoffman
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(3)
The 2.25 A crystal structure of a complex of Aurora A kinase (AIKA) with cyclopropanecarboxylic acid-(3-(4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino)-phenyl)-amide 1 is described here. The inhibitor binding mode is novel, with the cycloprop